Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (samples collected at enrollment)
Awards & highlights
Study Summary
This study explores the potential value of a new blood test approach for early detection of cancer.
Eligible Conditions
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (samples collected at enrollment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (samples collected at enrollment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cancer specific site prediction - blood samples/MDM
Cancer specific site prediction - blood samples/RNA
Cancer specific site prediction - urine samples/MDM
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo blood, urine, and/or residual tissue sample collection and have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,208 Previous Clinical Trials
3,761,200 Total Patients Enrolled
John B. Kisiel, M.D.Principal InvestigatorMayo Clinic in Rochester
3 Previous Clinical Trials
10,800 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger